Institute of Experimental Biomedicine I, University Hospital Würzburg, Würzburg Josef-Schneider-Straße 2, 97080 Wurzburg, Germany.
Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, 97080 Wurzburg, Germany.
Int J Mol Sci. 2021 Dec 29;23(1):358. doi: 10.3390/ijms23010358.
In hemostasis and thrombosis, the complex process of thrombus formation involves different molecular pathways of platelet and coagulation activation. These pathways are considered as operating together at the same time, but this has not been investigated. The objective of our study was to elucidate the time-dependency of key pathways of thrombus and clot formation, initiated by collagen and tissue factor surfaces, where coagulation is triggered via the extrinsic route. Therefore, we adapted a microfluidics whole-blood assay with the Maastricht flow chamber to acutely block molecular pathways by pharmacological intervention at desired time points. Application of the technique revealed crucial roles of glycoprotein VI (GPVI)-induced platelet signaling via Syk kinase as well as factor VIIa-induced thrombin generation, which were confined to the first minutes of thrombus buildup. A novel anti-GPVI Fab EMF-1 was used for this purpose. In addition, platelet activation with the protease-activating receptors 1/4 (PAR1/4) and integrin αIIbβ3 appeared to be prolongedly active and extended to later stages of thrombus and clot formation. This work thereby revealed a more persistent contribution of thrombin receptor-induced platelet activation than of collagen receptor-induced platelet activation to the thrombotic process.
在止血和血栓形成中,血栓形成的复杂过程涉及血小板和凝血激活的不同分子途径。这些途径被认为是同时运作的,但这一点尚未得到研究。我们的研究目的是阐明由胶原蛋白和组织因子表面引发的、通过外源性途径触发凝血的血栓和凝块形成的关键途径的时间依赖性。因此,我们通过药理学干预在所需的时间点适应了一种微流体全血测定法与马斯特里赫特流动室,以急性阻断分子途径。该技术的应用揭示了糖蛋白 VI(GPVI)诱导的血小板信号通过 Syk 激酶以及因子 VIIa 诱导的凝血酶生成的关键作用,这些作用仅限于血栓形成的最初几分钟。为此目的,使用了一种新型抗 GPVI Fab EMF-1。此外,蛋白酶激活受体 1/4(PAR1/4)和整合素 αIIbβ3 的血小板激活似乎持续活跃,并扩展到血栓和凝块形成的后期阶段。这项工作因此揭示了与胶原蛋白受体诱导的血小板激活相比,凝血酶受体诱导的血小板激活对血栓形成过程的持续贡献更大。